Inhibrx Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INBX | BMY | AMGN | GILD | VRTX |
| Company | Inhibrx Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 25.00 | 75.20 | 249.81 | 62.49 | 301.20 |
| High | 25.31 | 75.32 | 252.46 | 63.19 | 301.80 |
| Low | 22.65 | 73.95 | 248.53 | 62.11 | 295.11 |
| Last | 23.60 | 74.86 | 252.09 | 63.14 | 295.77 |
| Change | -0.94 | -0.10 | +3.73 | +1.14 | -3.06 |
| % Change | -3.83% | -0.13% | +1.50% | +1.84% | -1.02% |
| Volume | 561,800 | 8,319,000 | 2,628,600 | 8,275,000 | 1,432,500 |
| 20-Day Average Volume | 338,535 | 9,090,890 | 2,447,650 | 6,379,015 | 1,497,295 |
| Previous Close | 24.54 | 74.96 | 248.36 | 62.00 | 298.83 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 19.69 | 73.64 | 247.51 | 61.22 | 284.89 |
| 20-Day Raw Stochastic | 79.48% | 77.02% | 86.01% | 88.36% | 80.03% |
| 20-Day Relative Strength | 65.80% | 51.72% | 58.07% | 56.73% | 58.91% |
| Weighted Alpha | -52.70 | +14.20 | +13.10 | -9.50 | +54.90 |
| Today's Opinion | 8% Buy | 8% Buy | 100% Buy | 24% Sell | 100% Buy |
| Previous Opinion | 8% Buy | 16% Buy | 100% Buy | 24% Sell | 100% Buy |
| Last Month's Opinion | 56% Sell | 56% Buy | 80% Buy | 32% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +28.61% since 08/03/22 | +2.56% since 08/03/22 | +2.00% since 08/03/22 | +1.40% since 08/03/22 | +7.54% since 08/03/22 |
| Low | 18.12 on 08/04/22 | 71.71 on 08/05/22 | 241.79 on 08/05/22 | 60.62 on 08/05/22 | 272.10 on 08/05/22 |
| High | 25.52 on 08/09/22 | 75.51 on 08/09/22 | 252.46 on 08/10/22 | 63.19 on 08/10/22 | 301.80 on 08/10/22 |
| 1-Month | |||||
| %Chg | +37.05% since 07/08/22 | -0.69% since 07/08/22 | +1.45% since 07/08/22 | +0.48% since 07/08/22 | +0.50% since 07/08/22 |
| Low | 14.14 on 07/13/22 | 71.71 on 08/05/22 | 241.79 on 08/05/22 | 59.27 on 08/01/22 | 271.61 on 08/03/22 |
| High | 25.52 on 08/09/22 | 75.99 on 07/11/22 | 253.76 on 07/26/22 | 63.65 on 08/03/22 | 301.80 on 08/10/22 |
| 3-Month | |||||
| %Chg | +63.32% since 05/10/22 | -1.87% since 05/10/22 | +4.73% since 05/10/22 | +2.20% since 05/10/22 | +23.16% since 05/10/22 |
| Low | 7.67 on 06/16/22 | 71.71 on 08/05/22 | 229.49 on 06/17/22 | 57.17 on 06/14/22 | 233.01 on 05/11/22 |
| High | 25.52 on 08/09/22 | 80.59 on 06/27/22 | 257.97 on 06/01/22 | 65.46 on 05/26/22 | 301.80 on 08/10/22 |
| 6-Month | |||||
| %Chg | -3.08% since 02/10/22 | +12.55% since 02/10/22 | +10.17% since 02/10/22 | +2.18% since 02/10/22 | +25.38% since 02/10/22 |
| Low | 7.67 on 06/16/22 | 65.82 on 02/14/22 | 214.39 on 02/24/22 | 57.17 on 06/14/22 | 225.28 on 02/24/22 |
| High | 25.91 on 03/18/22 | 80.59 on 06/27/22 | 258.45 on 04/11/22 | 65.46 on 05/26/22 | 301.80 on 08/10/22 |
| Key Statistics | |||||
| Market Capitalization, $K | 921,273 | 159,845,184 | 134,850,752 | 79,197,320 | 75,852,880 |
| Shares Outstanding, K | 39,037 | 2,135,255 | 534,931 | 1,254,313 | 256,459 |
| Annual Sales | 7,230,000 | 46,385,000,000 | 25,979,000,000 | 27,305,000,000 | 7,574,400,000 |
| Annual Net Income | -81,770,000 | 6,994,000,000 | 5,893,000,000 | 6,225,000,000 | 2,342,100,000 |
| Last Quarter Sales | 930,000 | 11,887,000,000 | 6,594,000,000 | 6,260,000,000 | 2,196,200,000 |
| Last Quarter Net Income | -31,250,000 | 1,421,000,000 | 1,317,000,000 | 1,144,000,000 | 810,500,000 |
| 60-Month Beta | 3.24 | 0.40 | 0.56 | 0.34 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.97 on 08/08/22 | 1.93 on 07/27/22 | 4.65 on 08/04/22 | 1.58 on 08/02/22 | 3.60 on 08/04/22 |
| Latest Earnings Date | 08/08/22 | 07/27/22 | 08/04/22 | 08/02/22 | 08/04/22 |
| Most Recent Dividend | N/A | 0.540 on 06/30/22 | 1.940 on 05/16/22 | 0.730 on 06/14/22 | N/A |
| Next Ex-Dividends Date | N/A | 06/30/22 | 08/17/22 | 09/14/22 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 9.71 | 13.85 | 8.81 | 23.27 |
